Debt-to-equity of Guardant Health, Inc. from 30 Jun 2019 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Guardant Health, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2019 to 31 Dec 2025.
  • Guardant Health, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was -691%, a 86% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Guardant Health, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 -691% +4172% +86% 31 Dec 2025
Q3 2025 -618% -4535% -116% 30 Sep 2025
Q2 2025 -854% -2274% -160% 30 Jun 2025
Q1 2025 -1422% -2275% -267% 31 Mar 2025
Q4 2024 -4863% -5855% -590% 31 Dec 2024
Q3 2024 3917% +2758% +238% 30 Sep 2024
Q2 2024 1420% +118% +9.1% 30 Jun 2024
Q1 2024 853% -379% -31% 31 Mar 2024
Q4 2023 992% +416% +72% 31 Dec 2023
Q3 2023 1159% +785% +210% 30 Sep 2023
Q2 2023 1303% +1024% +368% 30 Jun 2023
Q1 2023 1232% +1005% +444% 31 Mar 2023
Q4 2022 576% +379% +192% 31 Dec 2022
Q3 2022 374% +230% +159% 30 Sep 2022
Q2 2022 279% +181% +187% 30 Jun 2022
Q1 2022 226% +167% +282% 31 Mar 2022
Q4 2021 197% +168% +572% 31 Dec 2021
Q3 2021 144% +132% +1094% 30 Sep 2021
Q2 2021 97% +85% +692% 30 Jun 2021
Q1 2021 59% +47% +381% 31 Mar 2021
Q4 2020 29% +18% +148% 31 Dec 2020
Q3 2020 12% +0.81% +7.2% 30 Sep 2020
Q2 2020 12% -0.2% -1.6% 30 Jun 2020
Q1 2020 12% 31 Mar 2020
Q4 2019 12% 31 Dec 2019
Q3 2019 11% 30 Sep 2019
Q2 2019 12% 30 Jun 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.